−0.257SEK
−59.30 MSEK
43.04 MSEK
204.41 M
About AROCELL AB (PUBL)
Sector
Industry
CEO
Anders Hultman
Website
Headquarters
Bromma Stockholm
Founded
2000
ISIN
SE0003883990
FIGI
BBG001Y25Z48
AroCell AB is a in vitro diagnostics company, which engages in the monitoring of hematological malignancies, breast cancer, and other solid tumors. Its products include AroCell TK 210 ELISA, which was designed for simple, robust, and scalable measurement of Thymidine Kinase 1 in blood samples. The company was founded by Karl Axel Staffan Eriksson, Arne Ferstad, Qi Min He, Per Nils Jesper Matsson, Sven Skog, and Bernhard Tribukait in 2003 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AROC is 0.35 SEK — it has decreased by 1.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange AROCELL AB (PUBL) stocks are traded under the ticker AROC.
One year price forecast for AROCELL AB (PUBL) has a max estimate of 1.30 SEK and a min estimate of 1.30 SEK.
AROCELL AB (PUBL) revenue for the last quarter amounts to 10.70 M SEK despite the estimated figure of 13.30 M SEK. In the next quarter revenue is expected to reach 11.60 M SEK.
Yes, you can track AROCELL AB (PUBL) financials in yearly and quarterly reports right on TradingView.
Like other stocks, AROC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROCELL AB (PUBL) stock right from TradingView charts — choose your broker and connect to your account.